Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luigi R Biasio

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Vaccine|April 28, 2007
Reply to "Panico MG, Caporale V, Attena F. Adverse events following hexavalent vaccine (Hexavac): knowledge and information sources"Luc Hessel, Fouzia Guenanèche, Luigi R Biasio, et al.
Advances in Therapy|February 26, 2010
Challenge with hepatitis B vaccine in children previously vaccinated with a hepatitis B-containing combination vaccinePhilippe Reinert, Sandro Cinquetti, Benoit Soubeyrand, et al.
Human Vaccines & Immunotherapeutics|July 27, 2016
Communication about vaccination: A shared responsibilityLuigi R Biasio, Giovanni Corsello, Claudio Costantino, et al.
Vaccine|October 20, 2006
Safety, tolerability, and immunogenicity of a two-dose regimen of high-titer varicella vaccine in subjects > or =13 years of ageClemente Diaz, Pietro Dentico, Rocio Gonzalez, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Vaccine|April 28, 2007
Reply to "Panico MG, Caporale V, Attena F. Adverse events following hexavalent vaccine (Hexavac): knowledge and information sources"Luc Hessel, Fouzia Guenanèche, Luigi R Biasio, et al.
Advances in Therapy|February 26, 2010
Challenge with hepatitis B vaccine in children previously vaccinated with a hepatitis B-containing combination vaccinePhilippe Reinert, Sandro Cinquetti, Benoit Soubeyrand, et al.
Human Vaccines & Immunotherapeutics|July 27, 2016
Communication about vaccination: A shared responsibilityLuigi R Biasio, Giovanni Corsello, Claudio Costantino, et al.
Vaccine|October 20, 2006
Safety, tolerability, and immunogenicity of a two-dose regimen of high-titer varicella vaccine in subjects > or =13 years of ageClemente Diaz, Pietro Dentico, Rocio Gonzalez, et al.
Pageof 1